NBIX - Neurocrine Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 58.84B
Enterprise Value 38.75B
Trailing P/E 536.21
Forward P/E 127.72
PEG Ratio (5 yr expected) 10.66
Price/Sales (ttm)14.60
Price/Book (mrq)18.47
Enterprise Value/Revenue 314.46
Enterprise Value/EBITDA 662.02

Trading Information

Stock Price History

Beta (3Y Monthly) 1.11
52-Week Change 3-19.71%
S&P500 52-Week Change 30.90%
52 Week High 3126.98
52 Week Low 364.72
50-Day Moving Average 391.48
200-Day Moving Average 384.68

Share Statistics

Avg Vol (3 month) 3666.67k
Avg Vol (10 day) 3520.76k
Shares Outstanding 591.28M
Float 90.22M
% Held by Insiders 11.27%
% Held by Institutions 1105.09%
Shares Short (Jul 31, 2019) 44.06M
Short Ratio (Jul 31, 2019) 45.62
Short % of Float (Jul 31, 2019) 45.98%
Short % of Shares Outstanding (Jul 31, 2019) 44.44%
Shares Short (prior month Jun 28, 2019) 44.14M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Dec 29, 1995
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 2.98%
Operating Margin (ttm)22.38%

Management Effectiveness

Return on Assets (ttm)8.87%
Return on Equity (ttm)4.20%

Income Statement

Revenue (ttm)605.23M
Revenue Per Share (ttm)6.66
Quarterly Revenue Growth (yoy)89.40%
Gross Profit (ttm)393.45M
EBITDA 141.15M
Net Income Avi to Common (ttm)18.07M
Diluted EPS (ttm)0.18
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)619.98M
Total Cash Per Share (mrq)6.77
Total Debt (mrq)468.4M
Total Debt/Equity (mrq)96.84
Current Ratio (mrq)7.44
Book Value Per Share (mrq)5.28

Cash Flow Statement

Operating Cash Flow (ttm)71.05M
Levered Free Cash Flow (ttm)88.88M